Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

3(50%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

83%

Ph phase_1

17%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

Phase 1Safety & dosage

1(16.7%)

N/ANon-phased studies

5(83.3%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(3)

Completed(3)

Detailed Status

Completed3

Recruiting3

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 1

Trials by Phase

Phase 11 (16.7%)

N/A5 (83.3%)

Trials by Status

completed350%

recruiting350%

Recent Activity

3 active trials

Showing 5 of 6

recruitingnot_applicable

Effects of Peanut Consumption on Postprandial Inflammation, Glucose and Triglycerides

NCT01173042

View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials

NCT06867198Not Applicable

Peanuts for Cardiometabolic, Brain, and Intestinal Health

Recruiting

NCT07244458Not Applicable

Dietary Peanuts and Nutrition-Related Outcomes

Recruiting

NCT07531849Not Applicable

Nutrition Labelling Education Program in Socioeconomically Vulnerable Areas

Recruiting

NCT05532007Not Applicable

Effects of Peanut Intake on Cognitive Functions

Completed

NCT01173042Phase 1

Effects of Peanut Consumption on Postprandial Inflammation, Glucose and Triglycerides

Completed

NCT00857402Not Applicable

Arginine as an Adjuvant Treatment Against Tuberculosis

Completed

All 6 trials loaded

Drug Details

Intervention Type: DIETARY SUPPLEMENT
Total Trials: 6